BACKGROUND & AIMS: Crohn's disease (CD) can develop in any region of the gastrointestinal tract, including the stomach. The etiology and pathogenesis of Crohn's gastritis are poorly understood, treatment approaches are limited, and there are not many suitable animal models for study. We characterized the features and mechanisms of chronic gastritis in SAMP1/YitFc (SAMP) mice, a spontaneous model of CD-like ileitis, along with possible therapeutic approaches. METHODS: Stomachs from specific pathogen-free and germ-free SAMP and AKR mice (controls) were evaluated histologically; the presence of Helicobacter spp was tested in fecal pellets by polymerase chain reaction analysis. In vivo gastric permeability was quantified by fractional excretion of sucrose, and epithelial tight junction protein expression was measured by quantitative reverse-transcription polymerase chain reaction analysis. The effects of a proton pump inhibitor (PPI) or corticosteroids were measured, and the ability of pathogenic immune cells to mediate gastritis was assessed in adoptive transfer experiments. RESULTS: SAMP mice developed Helicobacter-negative gastritis, characterized by aggregates of mononuclear cells, diffuse accumulation of neutrophils, and disruption of epithelial architecture; SAMP mice also had increased gastric permeability compared with controls, without alterations in expression of tight junction proteins. The gastritis and associated permeability defect observed in SAMP mice were independent of bacterial colonization and reduced by administration of corticosteroids but not a PPI. CD4(+) T cells isolated from draining mesenteric lymph nodes of SAMP mice were sufficient to induce gastritis in recipient SCID mice. CONCLUSIONS: In SAMP mice, gastritis develops spontaneously and has many features of CD-like ileitis. These mice are a useful model to study Helicobacter-negative, immune-mediated Crohn's gastritis.
BACKGROUND & AIMS:Crohn's disease (CD) can develop in any region of the gastrointestinal tract, including the stomach. The etiology and pathogenesis of Crohn's gastritis are poorly understood, treatment approaches are limited, and there are not many suitable animal models for study. We characterized the features and mechanisms of chronic gastritis in SAMP1/YitFc (SAMP) mice, a spontaneous model of CD-like ileitis, along with possible therapeutic approaches. METHODS: Stomachs from specific pathogen-free and germ-free SAMP and AKR mice (controls) were evaluated histologically; the presence of Helicobacterspp was tested in fecal pellets by polymerase chain reaction analysis. In vivo gastric permeability was quantified by fractional excretion of sucrose, and epithelial tight junction protein expression was measured by quantitative reverse-transcription polymerase chain reaction analysis. The effects of a proton pump inhibitor (PPI) or corticosteroids were measured, and the ability of pathogenic immune cells to mediate gastritis was assessed in adoptive transfer experiments. RESULTS:SAMPmice developed Helicobacter-negative gastritis, characterized by aggregates of mononuclear cells, diffuse accumulation of neutrophils, and disruption of epithelial architecture; SAMPmice also had increased gastric permeability compared with controls, without alterations in expression of tight junction proteins. The gastritis and associated permeability defect observed in SAMPmice were independent of bacterial colonization and reduced by administration of corticosteroids but not a PPI. CD4(+) T cells isolated from draining mesenteric lymph nodes of SAMPmice were sufficient to induce gastritis in recipient SCIDmice. CONCLUSIONS: In SAMPmice, gastritis develops spontaneously and has many features of CD-like ileitis. These mice are a useful model to study Helicobacter-negative, immune-mediated Crohn's gastritis.
Authors: M Matsumura; T Matsui; S Hatakeyama; H Matake; H Uno; T Sakurai; T Yao; T Oishi; A Iwashita; T Fujioka Journal: J Gastroenterol Date: 2001-11 Impact factor: 7.527
Authors: Theresa T Pizarro; Luca Pastorelli; Giorgos Bamias; Rekha R Garg; Brian K Reuter; Joseph R Mercado; Marcello Chieppa; Kristen O Arseneau; Klaus Ley; Fabio Cominelli Journal: Inflamm Bowel Dis Date: 2011-05-06 Impact factor: 5.325
Authors: Kevin G-E Scott; Jonathon B Meddings; David R Kirk; Susan P Lees-Miller; André G Buret Journal: Gastroenterology Date: 2002-10 Impact factor: 22.682
Authors: Paola Menghini; Daniele Corridoni; Ludovica F Buttó; Abdullah Osme; Sushma Shivaswamy; Minh Lam; Giorgos Bamias; Theresa T Pizarro; Alexander Rodriguez-Palacios; Charles A Dinarello; Fabio Cominelli Journal: Proc Natl Acad Sci U S A Date: 2019-12-16 Impact factor: 11.205
Authors: P B Ernst; L D Erickson; W M Loo; K G Scott; E B Wiznerowicz; C C Brown; F J Torres-Velez; M S Alam; S G Black; M McDuffie; S H Feldman; J L Wallace; G W McKnight; I T Padol; R H Hunt; K S Tung Journal: Am J Physiol Gastrointest Liver Physiol Date: 2011-09-15 Impact factor: 4.052
Authors: Sara Omenetti; Marco Brogi; Wendy A Goodman; Colleen M Croniger; Saada Eid; Alex Y Huang; Giacomo Laffi; Tania Roskams; Fabio Cominelli; Massimo Pinzani; Theresa T Pizarro Journal: Cell Mol Gastroenterol Hepatol Date: 2015-07-01
Authors: Carlo De Salvo; Luca Pastorelli; Christine P Petersen; Ludovica F Buttò; Kristine-Ann Buela; Sara Omenetti; Silviu A Locovei; Shuvra Ray; Hannah R Friedman; Jacob Duijser; Wei Xin; Abdullah Osme; Fabio Cominelli; Ganapati H Mahabeleshwar; Jason C Mills; James R Goldenring; Theresa T Pizarro Journal: Gastroenterology Date: 2020-10-01 Impact factor: 22.682